Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Ligand: Q4 Earnings Snapshot
Ligand: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 9:50 PM GMT+9 1 min read
In this article:
LGND
+1.26%
JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported fourth-quarter earnings of $44.8 million.
On a per-share basis, the Jupiter, Florida-based company said it had net income of $2.12. Earnings, adjusted for non-recurring gains, were $2.02 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share.
The drugmaker posted revenue of $59.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $58.2 million.
For the year, the company reported profit of $124.5 million, or $6.13 per share. Revenue was reported as $268.1 million.
Ligand expects full-year earnings in the range of $8 to $9 per share, with revenue in the range of $245 million to $285 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on LGND at
Terms and Privacy Policy
Privacy Dashboard
More Info